Yeah, he avoided Novartis discussion like the plague...let's see whether we get any questions pushing him on that clear gap. Maybe they weren't as impressed by the results as MSB was or thought they might be?
Okay, he did speak of it again, but no update beyond closing conditions, blah blah.
Ann: Mesoblast Q3 Financial Results Webcast, page-59
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
0.005(0.54%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 94.0¢ | 93.0¢ | $124.1K | 132.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 72917 | 93.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.5¢ | 17386 | 9 |
View Market Depth
| Last trade - 10.13am 10/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |